Skip to main content

Pathstone Holdings, LLC

Position in NBIX — Neurocrine Biosciences Inc

CIK 2011612 ENGLEWOOD, NJ

Position in NBIX

as of Mar 31, 2026 · filed May 11, 2026
Position Value
$1,562,041
-$129,564 QoQ
Shares Held
11,857
-0.6% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority Sole 69.89963734502825.ToString("F0")% Shared 0.969891203508476.ToString("F0")% None 29.13047145146327.ToString("F0")%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Pathstone Holdings, LLC holds $39,823,834 across 16 Drug Manufacturers - Specialty & Generic names. NBIX ranks #7 (3.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
7 NBIX
Neurocrine Biosciences Inc
This page
11,857 $1,562,041

All Filings in NBIX

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,562,041 11,857
2025-12-31 $1,691,605 11,927
2025-09-30 $1,581,099 11,263
2025-06-30 $1,414,640 11,255
2025-03-31 $934,901 8,453
2024-12-31 $1,204,885 8,827
2024-09-30 $788,910 6,847
2024-06-30 $1,313,783 9,543
2024-03-31 $736,077 5,337
2023-12-31 $839,047 6,368